125,80 <%= Resources.Global.txtDown %>
Opdateret 25-04-2018
Ændring % -1,49% Fald i aktiekurs
Ændring -1,90 Fald i aktiekurs
Volume 56.283
Høj 127,50
Lav 124,75
Åben 127,50
ISIN FR0010259150
Seneste luk 127,70
# af aktier 83,78M
Markedsværdi 10.540M EUR
I dag

Market closed
Ipsen
Markedet er lukket, åbner klokken 09:00
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  125,80 -1,7% Fald i aktiekurs 3,0% Stigning i aktiekurs 9,8% Stigning i aktiekurs 18,8% Stigning i aktiekurs 25,9% Stigning i aktiekurs
Powered by TradingView

Firmaprofil

Ipsen SA is a specialty and generic drug manufacturing company. The company's main therapeutic areas include oncology, endocrinology, neurosciences, and primary care. Ipsen maintains two segments: specialty care and primary care. The company derives most of its sales from the specialty care segment, with a vast majority of sales being generated in Western European countries. Ipsen's research and development strategy focuses on peptides and toxins. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Euroinvestor A/S 2018  Disclaimer Cookie- og privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. april 2018 05:50:37
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180423.5 - EUROWEB4 - 2018-04-26 05:50:37 - 2018-04-26 05:50:37 - 1 - Website: OKAY